Touro University
Welcome,         Profile    Billing    Logout  
 2 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Shubrook, Jay H
SURPASS-PEDS, NCT05260021 / 2021-003612-31: A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both

Active, not recruiting
3
99
Europe, US, RoW
Tirzepatide Dose 1, Tirzepatide Dose 2, Placebo
Eli Lilly and Company, Eli Lilly and Company
Type2 Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, T2D, T2DM (Type 2 Diabetes Mellitus), Glucose Metabolism Disorders, Endocrine System Diseases, Metabolic Disease
07/24
02/25
Schwarz, Jean-Marc
NCT02075710: Dietary Treatment Study of Fat Synthesis and Risk of Cardiovascular Disease

Active, not recruiting
N/A
48
US
High sugar/meal feed, High sugar/nibble, High fat/meal feed, High fat/nibble, High sugar/ 3 meals a day, High fat/ 3 meals a day
University of California, San Francisco, Touro University, California
Overweight and Obesity
12/22
12/22
NCT04168372: Fructose: Substrate, Stimulus, or Both?

Active, not recruiting
N/A
36
US
High fructose, fructose labeled meal, High fructose, pyruvate labeled meal, Low fructose, fructose labeled meal, Low fructose, pyruvate labeled meal
Touro University, California
Insulin Resistance, Insulin Sensitivity, Pre Diabetes
12/24
06/25
NCT03695315: Tissue-specific Insulin Resistance in Obstructive Sleep Apnea: Role of Hypoxia

Active, not recruiting
N/A
60
US
Continuous Positive Airway Pressure
University of California, San Francisco, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Obstructive Sleep Apnea, Hypoxia, Insulin Resistance
12/25
12/25

Download Options